COMMUNIQUÉS West-GlobeNewswire

aTyr Pharma to Host Conference Call and Webcast of First Quarter 2018 Financial Results on May 14, 2018

08/05/2018 - 14:00

SAN DIEGO, May 08, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]

Aeglea BioTherapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Results

08/05/2018 - 14:00

AUSTIN, Texas, May 08, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE ), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare [...]

Athenex to Present at Deutsche Bank’s 43rd Annual Health Care Conference

08/05/2018 - 14:00

BUFFALO, N.Y., May 08, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

Daré Bioscience, Inc. Expands Leadership Team, Appointing John Fair to Chief Business Officer

08/05/2018 - 14:00

SAN DIEGO, May 08, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a clinical-stage, women’s biopharmaceutical company, today announced it has appointed Mr. Fair to the newly created position of Chief [...]

Allena Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update

08/05/2018 - 14:00

-- Initiated Phase 3 Study URIROX-1™ and Phase 2 Study 206 for ALLN-177 in Patients with Severe Hyperoxaluria -- -- Reiterates Guidance for Key Objectives Across Portfolio-- NEWTON, Mass., May 08, 2018 (GLOBE NEWSWIRE [...]

Corium to Report Second Quarter Fiscal 2018 Financial Results on Monday, May 14, 2018

08/05/2018 - 14:00

MENLO PARK, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ: CORI ) today announced that it will report financial results for the second quarter ended March 31, 2018 on Monday, May 14, 2018 [...]

iCAD to Report First Quarter 2018 Financial Results on Monday, May 14, 2018

08/05/2018 - 14:00

NASHUA, N.H., May 08, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD ), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of [...]

Relypsa Announces FDA Approval of Supplemental New Drug Application to Enable the Usage of Veltassa® (patiromer) With or Without Food

08/05/2018 - 14:00

Updated label may allow for increased dosing flexibility for patients with hyperkalemia (elevated blood potassium) – a chronic, asymptomatic condition that often coexists with other disorders, including chronic kidney [...]

Sim Farar Joins BioSig Technologies Advisory Board

08/05/2018 - 14:00

Los Angeles based business leader and political adviser to support strategic plans Santa Monica, CA, May 08, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a [...]

Golden Leaf Holdings to Present at Canaccord Genuity's 2nd Annual Cannabis Conference

08/05/2018 - 14:00

PORTLAND, Ore., May 08, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company and dispensary operator built around recognized [...]

PCI Biotech: Notice of Annual General Meeting 2018

08/05/2018 - 12:01

Oslo, Norway 8 May 2018 - The shareholders of PCI Biotech Holding ASA are invited to attend the Annual General Meeting 2018 at Oslo Cancer Cluster Innovation Park. Time: Monday May 29, 10am CEST (local time). Venue: [...]

Horizon Discovery Group plc: Preliminary Results for the Year Ended 31 December 2017

08/05/2018 - 12:00

Horizon Discovery Group plc ("Horizon" or "the Company" or "the Group") Preliminary Results for the Year Ended 31 December 2017 Cambridge, UK, 8 May 2018: Horizon Discovery Group plc (LSE: HZD), a global leader in gene [...]

Horizon Discovery Group plc: Revenue Multiple Represented by the Value of Abcam's Unsolicited Proposal

08/05/2018 - 12:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION FOR [...]

Horizon Discovery appoints Terry Pizzie as Chief Executive Officer

08/05/2018 - 12:00

Horizon Discovery Group plc Horizon Discovery appoints Terry Pizzie as Chief Executive Officer Cambridge, UK, 8 May 2018: Horizon Discovery Group plc (LSE: HZD) ("Horizon", "the Group" or "the Company"), a global leader [...]

Sernova Announces U.S. Phase I/II Cell Pouch Clinical Trial with Prominent Diabetes Clinical Investigator

08/05/2018 - 12:00

Leading Surgeon and Researcher in Islet Transplantation at the University of Chicago to act as Clinical Trial Principal Investigator. Study to focus on severely diabetic patients with hypoglycemia unawareness LONDON, [...]

CureVac Announces New Management Structure

08/05/2018 - 12:00

Founder Ingmar Hoerr to transition to Chairman role; Daniel Menichella to become CEO TÜBINGEN, Germany and BOSTON, May 08, 2018 (GLOBE NEWSWIRE) -- CureVac AG, a fully-integrated biopharmaceutical company pioneering the [...]

Invivoscribe Submits Pre-Market Approval Application in Japan and Panel Track Supplement in the US to Screen Acute Myeloid Leukemia (AML) Patients for FLT3 Mutations

08/05/2018 - 12:00

SAN DIEGO, May 08, 2018 (GLOBE NEWSWIRE) -- Invivoscribe Technologies, Inc. announced today that they have submitted to Japan’s Pharmaceutical and Medical Devices Agency (PMDA) and the US Food and Drug Administration ( [...]

BioCryst Reports First Quarter 2018 Financial Results

08/05/2018 - 12:00

RESEARCH TRIANGLE PARK, N.C., May 08, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) announced today financial results for the first quarter ended March 31, 2018. “We are off to a strong start [...]

Mesoblast Phase 3 Trial Results for Acute Graft Versus Host Disease Presented at 2018 International Society for Cell and Gene Therapy Annual Meeting

08/05/2018 - 12:00

NEW YORK and MELBOURNE, Australia, May 08, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO ) (ASX:MSB) today announced that results of the Phase 3 trial evaluating its product candidate MSC-100-IV (remestemcel- [...]